🌿 Will Cannaponics crowd funding go up in smoke? 🔥

PLUS: CBD anti-inflammatory trial results 💊, Nimbin Mardi Grass 2023

Good morning. Welcome to The Greenfields. We hope you’ve had your medicine this morning.

What’ve we got for you today?

  • Will Cannaponics crowd funding go up in smoke? 🔥 

  • CBD anti-inflammatory trial results 💊 

  • Nimbin Mardi Grass 2023 🌿 

Will Cannaponics crowd funding go up in smoke? 🔥

Cannaponics has raised $3.2 million from 1700 investors via crowdfunding. All in less than 24 hours. And probably a bit more by the time you read this.

That money will go towards their new 1MW solar farm, validation of their headhouse facility (where pre/post harvest, potting and stuff happens), and fit out of their quality assurance facility. Once the headhouse is completed in 6-9 months (September or October this year) they will start production.

It’s not clear if they’ll make their stretch goals at $4 and $5 million. If they reach $4m they’ll buy Nano-emulsion processing equipment. At $5m they’ll buy machinery to produce isolates and distillates. There’s about 15 days remaining.

Cannaponics were founded in 2018-2019. They completed construction of their greenhouse facility in August 2022.

To date they’ve raised $12 million in funding from government grants and investors. That’s a lot to have spent with production still another 6-9 months away. We want to see everyone succeed in cannabis and and hope the only thing going up in smoke is some dried flower.

Photos of People (or cats) Surrounded by Cannabis

This weeks Photos of People (or cats) Surrounded by Cannabis is courtesy of Honeydew Farms.

This is them surrounded by some beautiful outdoor cannabis.

Good for you Honeydew Farms.

If you'd like to see your photo in Photos of People (or cats) Surrounded by Cannabis share it with us on Twitter, Facebook, LinkedIn or Instagram.

Do you have friends?

Don’t let them get left behind. Send them this email now.

Are you the friend? Click the button to subscribe for free:

CBD Anti-Inflammatory Trial results

A new Anti-Inflammatory from Incannex Health (ASX:IHL) has passed Phase 1 trials that found it to be safe and well tolerated.

IHL-675A is a cannabinoid anti-inflammatory drug for treating Rheumatoid Arthritis, COPD, Asthma, Bronchotis, Colitis, and Crohns disease. Incannex says this market is worth $125 Billion based on the performance of other drugs on the market.

They’ve started Phase 2 trials for Rheumatoid arthritis and are planning Phase 2 trials for Inflammatory Lung conditions and Inflammatory bowel disease. The Phase 2 trials will asses the safety and effectiveness of the drug.

Dr. Lenny's Lab

Got a question about cannabis you'd like answered by an actual scientist?

Dr. Lenny is a plant and brain scientist that can answer your questions about cannabis, plants, brains, research, medicine, and biology.

Reply to this email with your questions and the best one will get an answer in an upcoming newsletter.

Nimbin Mardi Grass 2023

Roll up and celebrate at Nimbin’s Mardi Grass cannabis festival this weekend. The festival is a protest against the prohibition of cannabis and an opportunity to high (😉) light the benefits of cannabis.

This year's event will be even more epic, thanks to the recent election of Legalise Cannabis MP Jeremy Buckingham and the presence of other like-minded Green senators. You can expect an all-star lineup of comedians, including Cannabis entrepreneur Jason Gann, aka Wilfred.

For those who love a bit of friendly competition, the festival also features the famous Hemp Olympix. This is a chance to show off your skills in events such as the Joint Rolling competition and the world stoned chess championship.

Tickets are available here

What did you think of todays newsletter?

A reader says:

That’s your walk through The Greenfields of the cannabis industry today. We hope you've enjoyed it.

We’ll see you again on Tuesday, but if you want more follow us on Twitter, Facebook, or LinkedIn.

DISCLAIMER: This newsletter is not financial advice. It is strictly educational and is not investment advice or a solicitation to buy or sell anything or to make any financial decisions. Please do your own research and do not buy anything dodgy

Reply

or to participate.